Sunday, March 9, 2025

Healthcare

Breaking New Ground in Epilepsy Treatment: Bright Minds’ Revolutionary Therapies

Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders. One such therapy involves healing the...

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Bright Minds Biosciences has announced the commencement of its Phase 2 clinical trial for BMB-101.  On September 25th, the company will host an event to...

The Future of Cancer Therapy is Here

RenovoRx's TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy. With a projected 330% price increase, RenovoRx is gaining investor...

Advancing Neurological Solutions with Game-Changing Science

Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, such as healing the central nervous...

Investing in Biotech: Why 2024 Could Be the Year of Major Gains

2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector. Gene therapy and oncology are driving biotech...

Popular

Subscribe